Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Summary

This study is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of the TEAD inhibitor TYK-01054 capsules in patients with locally advanced or metastatic advanced solid tumors

Timeline

Start

2026-01-01

Primary completion

2028-01

Completion

2029-06

Drugs

Indications